Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

394 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Diabetes and Coronary Artery Disease: Translating the Benefits of the Molecular Mechanisms of Gliflozins into Clinical Practice.
Cesaro A, Acerbo V, Vetrano E, Signore G, Scherillo G, Rotolo FP, De Michele G, Scialla F, Raucci G, Panico D, Gragnano F, Moscarella E, Galiero R, Caturano A, Ruggiero R, Sasso FC, Calabrò P. Cesaro A, et al. Among authors: moscarella e. Int J Mol Sci. 2023 Apr 30;24(9):8099. doi: 10.3390/ijms24098099. Int J Mol Sci. 2023. PMID: 37175805 Free PMC article.
Impact of clinical presentation on ischaemic and bleeding outcomes in patients receiving 6- or 24-month duration of dual-antiplatelet therapy after stent implantation: a pre-specified analysis from the PRODIGY (Prolonging Dual-Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia) trial.
Costa F, Vranckx P, Leonardi S, Moscarella E, Ando G, Calabro P, Oreto G, Zijlstra F, Valgimigli M. Costa F, et al. Among authors: moscarella e. Eur Heart J. 2015 May 21;36(20):1242-51. doi: 10.1093/eurheartj/ehv038. Epub 2015 Feb 25. Eur Heart J. 2015. PMID: 25718355 Clinical Trial.
Bioresorbable vascular scaffold implantation for the treatment of coronary in-stent restenosis: results from a multicenter Italian experience.
Moscarella E, Varricchio A, Stabile E, Latib A, Ielasi A, Tespili M, Cortese B, Calabrò P, Granata F, Panoulas VF, Franzone A, Trimarco B, Bonzani G, Esposito G, Colombo A. Moscarella E, et al. Int J Cardiol. 2015 Nov 15;199:366-72. doi: 10.1016/j.ijcard.2015.07.002. Epub 2015 Jul 11. Int J Cardiol. 2015. PMID: 26241643
Functional assessment of coronary stenosis: an overview of available techniques. Is quantitative flow ratio a step to the future?
Cesaro A, Gragnano F, Di Girolamo D, Moscarella E, Diana V, Pariggiano I, Alfieri A, Perrotta R, Golino P, Cesaro F, Mercone G, Campo G, Calabrò P. Cesaro A, et al. Among authors: moscarella e. Expert Rev Cardiovasc Ther. 2018 Dec;16(12):951-962. doi: 10.1080/14779072.2018.1540303. Epub 2018 Nov 1. Expert Rev Cardiovasc Ther. 2018. PMID: 30352515 Review.
Impact of PCSK9 inhibitors on the quality of life of patients at high cardiovascular risk.
Cesaro A, Gragnano F, Fimiani F, Moscarella E, Diana V, Pariggiano I, Concilio C, Natale F, Limongelli G, Bossone E, Calabrò P. Cesaro A, et al. Among authors: moscarella e. Eur J Prev Cardiol. 2020 Mar;27(5):556-558. doi: 10.1177/2047487319839179. Epub 2019 Mar 26. Eur J Prev Cardiol. 2020. PMID: 30913901 No abstract available.
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in patients presenting with acute myocardial infarction: Insight from the ULISSE registry.
Moscarella E, Ielasi A, Beneduce A, Ferrante G, Pivato CA, Chiarito M, Cappelletti A, Perfetti G, Magni V, Prati E, Falcone S, Pierri A, De Martini S, Montorfano M, Parisi R, Rutigliano D, Locuratolo N, Anzuini A, Calabrò P, Tespili M, Margonato A, Benassi A, Briguori C, Fabbiocchi F, Reimers B, Bartorelli A, Colombo A, Godino C. Moscarella E, et al. Catheter Cardiovasc Interv. 2019 Dec 1;94(7):972-979. doi: 10.1002/ccd.28305. Epub 2019 Apr 29. Catheter Cardiovasc Interv. 2019. PMID: 31037840
Transradial access versus transfemoral access: a comparison of outcomes and efficacy in reducing hemorrhagic events.
Cesaro A, Moscarella E, Gragnano F, Perrotta R, Diana V, Pariggiano I, Concilio C, Alfieri A, Cesaro F, Mercone G, Falato S, Esposito A, Di Girolamo D, Limongelli G, Calabrò P. Cesaro A, et al. Among authors: moscarella e. Expert Rev Cardiovasc Ther. 2019 Jun;17(6):435-447. doi: 10.1080/14779072.2019.1627873. Expert Rev Cardiovasc Ther. 2019. PMID: 31213156 Review.
Effect of Body Mass Index on Ischemic and Bleeding Events in Patients Presenting With Acute Coronary Syndromes (from the START-ANTIPLATELET Registry).
Calabrò P, Moscarella E, Gragnano F, Cesaro A, Pafundi PC, Patti G, Cavallari I, Antonucci E, Cirillo P, Pignatelli P, Palareti G, Sasso FC, Pengo V, Gresele P, Marcucci R; START-ANTIPLATELET collaborators; Conte M, Fimiani F, Di Serafino L, Del Pinto M, Denas G, Pastori D, Eleonora C, Fierro T. Calabrò P, et al. Among authors: moscarella e. Am J Cardiol. 2019 Dec 1;124(11):1662-1668. doi: 10.1016/j.amjcard.2019.08.030. Epub 2019 Sep 6. Am J Cardiol. 2019. PMID: 31585697
394 results